ArticleDiabetology & metabolic syndrome2012

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial.

Robert Frederich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.